Screening and Molecular Diagnosis-based Individualized Precision Management of Monogenic Diabetes

Recruiting now · Not applicable

Conditions studied: Monogenic Diabetes

In brief

The goal of this observational study is to establish a registry, screening, and individualized management platform for patients with monogenic diabetes mellitus(MDM) using internet-based and mobile application software. The main questions it aims to answer are: * What are the genetic mutations causing MDM in China (genetic landscape)? * How effective and safe is the individualized, molecular-diagnosis-based management platform for MDM in improving patient outcomes? Participants will: * Register in the MDM platform via mobile app or internet-based software * Undergo genetic screening for MDM diagnosis * Participate in follow-up visits for individualized management and monitoring of blood glucose control and outcomes

Key facts

Study ID
NCT06746610
Run by
Tianjin Medical University General Hospital
People needed
2000
Starts
2022-08-01
Expected to finish
2027-07-31
Last updated by the study team
2024-12-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.